Acquired Appetitive Responding to Intravenous Nicotine Reflects a Pavlovian Conditioned Association

Behavioral Neuroscience

Volumn 123, Issue 1, 2009, Pages 97-108

  Murray, Jennifer E ^a   Bevins, Rick A ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

appetitive conditioned response; drug stimulus; IV nicotine; Pavlovian drug discrimination; smoking cessation

Indexed keywords

ANALYSIS OF VARIANCE; ANIMALS; APPETITIVE BEHAVIOR; ASSOCIATION LEARNING; CONDITIONING, CLASSICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTINCTION, PSYCHOLOGICAL; FOOD PREFERENCES; INJECTIONS, INTRAVENOUS; MALE; MECAMYLAMINE; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 60549087336     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0013735     Document Type: Article

References (90)

1. Asghar K., and Roth L.J. Entry and distribution of hexamethonium in the central nervous system. Biochemical Pharmacology 20 (1971) 2787-2795
2. Ayers J.J.B., and DeCosta M.J. The truly random control as an extinction procedure. Psychonomic Science 24 (1971) 31-33
3. Benowitz N.L. Pharmacokinetic considerations in understanding nicotine dependence. In: Bock G., and Marsh J. (Eds). The biology of nicotine dependence (1990), Wiley, Chichester, New York 186-209
4. Benowitz N.L. Pharmacology of nicotine: Addiction and therapeutics. Annual Review of Pharmacology and Toxicology 36 (1996) 597-613
5. Benowitz N.L., Porchet H., and Jacob P. Pharmacokinetics, metabolism, and pharmacodynamics of nicotine. In: Wonnacott S., Russell M.A.H., and Stolerman I.P. (Eds). Nicotine psychopharmacology: Molecular, cellular, and behavioural aspects (1990), Oxford University Press, Oxford 112-157
6. Besheer J., Palmatier M.I., Metschke D.M., and Bevins R.A. Nicotine as a signal for the presence or absence of sucrose reward: A Pavlovian drug appetitive conditioning preparation in rats. Psychopharmacology 172 (2004) 108-117
7. Bevins R.A. The reference-dose place conditioning procedure yields a graded dose-effect function. International Journal of Comparative Psychology 18 (2005) 101-111
8. Bevins R.A., and Palmatier M.I. Nicotine-conditioned locomotor sensitization in rats: Assessment of the US-preexposure effect. Behavioural Brain Research 14 (2003) 365-374
9. Bevins R.A., and Palmatier M.I. Extending the role of associative learning processes in nicotine addiction. Behavioral and Cognitive Neuroscience Reviews 3 (2004) 143-158
10. Bevins R.A., Penrod R.D., and Reichel C.M. Nicotine does not produce state-dependent effects on learning in a Pavlovian appetitive goal-tracking task in rats. Behavioural Brain Research 177 (2007) 134-141
11. Boakes R.A. Performance on learning to associate a stimulus with positive reinforcement. In: Davis H., and Hurwitz H.M.B. (Eds). Operant-Pavlovian interactions (1977), Erlbaum, New Jersey 67-97
12. Booze R.M., Welch M.A., Wood M.L., Billings K.A., Apple S.R., and Mactutus C.F. Behavioral sensitization following repeated intravenous nicotine administration: Gender differences and gonadal hormones. Pharmacology, Biochemistry and Behavior 64 (1999) 827-839
13. Bouton M.E. Context, time, and memory retrieval in the interference paradigms of Pavlovian learning. Psychological Bulletin 114 (1993) 80-99
14. Brazell M.P., Mitchell S.N., and Gray J.A. Effect of acute administration of nicotine on in vivo release of noradrenaline in the hippocampus of freely moving rats: A dose-response and antagonist study. Neuropharmacology 30 (1991) 823-833
15. CDC. Cigarette smoking among adults-United States, 2000. MMWR 51 (2002) 642-645
16. CDC. Cigarette smoking among adults-United States, 2006. MMWR 56 (2007) 1157-1161
17. Chaudhri N., Caggiula A.R., Donny E.C., Booth S., Gharib M., Craven L., et al. Operant responding for conditioned and unconditioned reinforcers in rats is differentially enhanced by the primary reinforcing and reinforcement-enhancing effects of nicotine. Psychopharmacology 189 (2006) 27-36
18. Chaudhri N., Caggiula A.R., Donny E.C., Booth S., Gharib M., Craven L., et al. Self-administered and noncontingent nicotine enhance reinforced operant responding in rats: Impact of nicotine dose and reinforcement schedule. Psychopharmacology 190 (2007) 353-362
19. Childress A.R., Hole A.V., Ehrman R.N., Robbins S.J., McLellan A.T., and O'Brien C.P. Cue reactivity and cue reactivity interventions in drug dependence. NIDA Research Monograph 137 (1993) 73-95
20. Clements K., Glautier S., Stolerman I.P., White J.-A.W., and Taylor C. Classical conditioning in humans: Nicotine as CS and alcohol as US. Human Psychopharmacology 11 (1996) 85-95
21. Conklin C.A. Environments as cues to smoke: Implications for human extinction-based research and treatment. Experimental and Clinical Psychopharmacology 14 (2006) 12-19
22. Conklin C.A., and Tiffany S.T. The impact of imagining personalized versus standardized urge scenarios on cigarette craving and autonomic reactivity. Experimental and Clinical Psychopharmacology 9 (2001) 399-408
23. Conklin C.A., and Tiffany S.T. Applying extinction research and theory to cue-exposure addiction treatments. Addiction 97 (2002) 155-167
24. Corrigall W.A., and Coen K.M. Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology 99 (1989) 473-478
25. Corrigall W.A., and Coen K.M. Selective dopamine antagonists reduce nicotine self-administration. Psychopharmacology 104 (1991) 171-176
26. Donny E.C., Caggiula A.R., Knopf S., and Brown C. Nicotine self-administration in rats. Psychopharmacology 122 (1995) 390-394
27. Donny E.C., Caggiula A.R., Mielke M.M., Jacobs K.S., Rose C., and Sved A.F. Acquisition of nicotine self-administration in rats: The effects of dose, feeding schedule, and drug contingency. Psychopharmacology 136 (1998) 83-90
28. Donny E.C., Chaudhri N., Caggiula A.R., Evans-Martin F.F., Booth S., Gharib M.A., et al. Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: Implications for nicotine self-administration and reinforcement. Psychopharmacology 169 (2003) 68-76
29. Drummond D.C., Tiffany S.T., Glautier S., and Remington B. Cue exposure in understanding and treating addictive behaviours. In: Drummond D.C., Tiffany S.T., Glautier S., and Remington B. (Eds). Addictive behavior: Cue exposure theory and practice (1995), Wiley, Oxford 1-17
30. Eguchi S., Miyashita S., Kitamura Y., and Kawasaki H. Alpha3beta4-nicotinic receptors mediate adrenergic nerve- and peptidergic (CGRP) nerve-dependent vasodilation induced by nicotine in rat mesenteric arteries. British Journal of Pharmacology 151 (2007) 1216-1223
31. Esson C.M., and Leeder S.R. The millennium development goals and tobacco control: An opportunity for global partnership (2004), World Health Organization, France
32. Farwell B.J., and Ayres J.J.B. Stimulus-reinforcer and response-reinforcer relations in the control of conditioned appetitive headpoking ("goal-tracking") in rats. Learning and Motivation 10 (1979) 295-312
33. Fenster C.P., Rains M.F., Noerager B., Quick M.W., and Lester R.A.J. Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. The Journal of Neuroscience 17 (1997) 5747-5759
34. General Assembly. United Nations millennium declaration. Resolution 55/2 (2000). http://www.un.org/millennium/declaration/ares552e.pdf Retrieved February 21, 2008, from http://www.un.org/millennium/declaration/ares552e.pdf
35. Groves P.M., and Thompson R.F. Habituation: A dual-process theory. Psychological Review 77 (1970) 419-450
36. Henningfield J.E., Stapleton J.M., Benowitz N.L., Grayson R.F., and London E.D. Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug and Alcohol Dependence 33 (1993) 23-29
37. Kalish H.I. Strength of fear as a function of the number of acquisition and extinction trials. Journal of Experimental Psychology 47 (1954) 1-9
38. Lembeck F. Epibatidine: High potency and broad spectrum activity on neuronal and neuromuscular nicotinic acetylcholine receptors. Naunyn-Schmiedeberg's Archives of Pharmacology 359 (1999) 378-385
39. LeSage M.G., Keyler D.E., Collins G., and Pentel P.R. Effects of continuous nicotine infusion on nicotine self-administration in rats: Relationship between continuously infused and self-administered nicotine doses and serum concentrations. Psychopharmacology 170 (2003) 278-286
40. LeSage M.G., Keyler D.E., Shoeman D., Raphael D., Collins G., and Pentel P.R. Continuous nicotine infusion reduces nicotine self-administration in rats with 23-h/day access to nicotine. Pharmacology, Biochemistry, & Behavior 72 (2002) 279-289
41. Loughlin S.E., Islas M.I., Cheng M.Y., Lee A.G., Villegier A.S., and Leslie F.M. Nicotine modulation of stress-related peptide neurons. The Journal of Comparative Neurology 497 (2006) 575-588
42. Marlatt G.A. Cue exposure and relapse prevention in the treatment of addictive behaviors. Addictive Behaviors 15 (1990) 395-399
43. Matta S.G., Balfour D.J., Benowitz N.L., Boyd R.T., Buccafusco J.J., Caggiula A.R., et al. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology 190 (2007) 269-319
44. McGehee D.S., Heath M.J.S., Gelber S., Devay P., and Role L.W. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269 (1995) 1692-1696
45. McSweeney F.K. Rate of reinforcement and session duration as determinants of within-session patterns of responding. Animal Learning & Behavior 20 (1992) 160-169
46. McSweeney F.K., and Hinson J.M. Patterns of responding within sessions. Journal of the Experimental Analysis of Behavior 58 (1992) 19-36
47. McSweeney F.K., Hinson J.M., and Cannon C.B. Sensitization-habituation may occur during operant conditioning. Psychological Bulletin 120 (1996) 256-271
48. McSweeney F.K., and Swindell S. General-process theories of motivation revisited: The role of habituation. Psychological Bulletin 125 (1999) 437-457
49. Morris W.R., and Bouton M.E. Effect of unconditioned stimulus magnitude on the emergence of conditioned responding. Journal of Experimental Psychology: Animal Behavior Processes 32 (2006) 371-385
50. Morrison C.F., and Stephenson J.A. Nicotine injections as the conditioned stimulus in discrimination learning. Psychopharmacologia 15 (1969) 351-360
51. Murphy R.A., and Baker A.G. A role for CS-US contingency in Pavlovian conditioning. Journal of Experimental Psychology: Animal Behavior Processes 30 (2004) 229-239
52. Murray J.E., and Bevins R.A. Behavioral and neuropharmacological characterization of nicotine as a conditional stimulus. European Journal of Pharmacology 561 (2007) 91-104
53. Murray J.E., and Bevins R.A. The conditional stimulus effects of nicotine vary as a function of training dose. Behavioural Pharmacology 18 8 (2007) 707-716
54. Murray J.E., Li C., Palmatier M.I., and Bevins R.A. The interoceptive Pavlovian stimulus effects of caffeine. Pharmacology, Biochemistry and Behavior 86 (2007) 838-846
55. National Research Council. Guide for the care and use of laboratory animals (1996), National Academy Press, Washington, DC
56. Olausson P., Jentsch J.D., and Taylor J.R. Repeated nicotine exposure enhances reward-related learning in the rat. Neuropsychopharmacology 28 (2003) 1264-1271
57. Palmatier M.I., and Bevins R.A. Facilitation by drug states does not depend on acquired excitatory strength. Behavioural Brain Research 176 (2007) 292-301
58. Palmatier M.I., Evans-Martin F.F., Hoffman A., Caggiula A.R., Chaudhri N., Donny E.C., et al. Dissociating the primary reinforcing and reinforcement-enhancing effects of nicotine using a rat self-administration paradigm with concurrently available drug and environmental reinforcers. Psychopharmacology 184 (2006) 391-400
59. Papke R.L., Sanberg P.R., and Shytle R.D. Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. Journal of Pharmacology and Experimental Therapeutics 297 (2001) 646-656
60. Parrott A.C. Nicotine psychobiology: How chronic-dose prospective studies can illuminate some of the theoretical issues from acute-dose research. Psychopharmacology 184 (2006) 567-576
61. Parrott A.C., and Garnham N.J. Comparative mood states and cognitive skills of cigarette smokers, deprived smokers, and non-smokers. Human Psychopharmacology 13 (1998) 367-376
62. Parrott A.C., and Kaye F.J. Daily uplifts, hassles, stresses and cognitive failures: In cigarette smokers, abstaining smokers, and non-smokers. Behavioural Pharmacology 10 (1999) 639-646
63. Pavlov I.P. Conditioned reflexes (1927), Oxford University Press, London
64. Payne T.J., Schare M.L., Levis D.J., and Colletti G. Exposure to smoking-relavent cues: Effects on desire to smoke and topographical components of smoking behavior. Addictive Behaviors 16 (1991) 467-479
65. Pidoplichko V.I., DeBiasi M., Williams J.T., and Dani J.A. Nicotine activates and desensitizes midbrain dopamine neurons. Nature 390 (1997) 401-404
66. Poulos C.X., Hinson R.E., and Siegel S. The role of Pavlovian processes in drug tolerance and dependence: Implications for treatment. Addictive Behaviors 6 (1981) 205-211
67. Rauhut A.S., Dwoskin L.P., and Bardo M.T. Tolerance does not develop to the decrease in nicotine self-administration produced by repeated bupropion administration. Nicotine & Tobacco Research 7 (2005) 901-907
68. Rauhut A.S., Mullins S.N., Dwoskin L.P., and Bardo M.T. Reboxetine: Attenuation of intravenous nicotine self-administration in rats. The Journal of Pharmacology and Experimental Therapeutics 303 (2002) 664-672
69. Reichel C.M., Linkugel J.D., and Bevins R.A. Nicotine as a conditioned stimulus: Impact of attention deficit/hyperactivity disorder medication. Experimental and Clinical Psychopharmacology 15 (2007) 501-509
70. Reichel C.M., Linkugel J.D., and Bevins R.A. Bupropion differentially impacts acquisition of methamphetamine self-administration and sucrose-maintained behavior. Pharmacology, Biochemistry and Behavior 89 (2008) 463-472
71. Rescorla R.A. Spontaneous recovery after Pavlovian conditioning with multiple outcomes. Animal Learning & Behavior 25 (1997) 99-107
72. Rescorla R.A. Spontaneous recovery. Learning & Memory 11 (2004) 501-509
73. Revell A.D. Smoking and performance: A puff-by-puff analysis. Psychopharmacology 96 (1988) 563-565
74. Russell M.A. Subjective and behavioural effects of nicotine in humans: Some sources of individual variation. Progress in Brain Research 79 (1989) 289-302
75. Servatius R.J., Brennan F.X., Beck K.D., Beldowicz D., and Coyle-DiNorcia K. Stress facilitates acquisition of the classically conditioned eyeblink response at both long and short interstimulus intervals. Learning and Motivation 32 (2001) 178-192
76. Shiffman S., Gwaltney C.J., Balabanis M.H., Liu K.S., Paty J.A., Kassel J.D., et al. Immediate antecedents of cigarette smoking: An analysis from ecological momentary assessment. Journal of Abnormal Psychology 111 (2002) 531-545
77. Shoaib M., and Stolerman I.P. MK801 attenuates behavioural adaptation to chronic nicotine administration in rats. British Journal of Pharmacology 105 (1992) 514-515
78. Simon N.W., and Setlow B. Post-training amphetamine administration enhances memory consolidation in appetitive Pavlovian conditioning: Implications for drug addiction. Neurobiology of Learning and Memory 86 (2006) 305-310
79. Stolerman I.P. Inter-species consistency in the behavioural pharmacology of nicotine dependence. Behavioural Pharmacology 10 (1999) 559-580
80. Stolerman I.P., Garcha H.S., Pratt J.A., and Kumar R. Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacology 84 (1984) 413-419
81. Swithers-Mulvey S.E., and Hall W.G. Control of ingestion by oral habituation in rat pups. Behavioral Neuroscience 106 (1992) 710-717
82. Takada K., Hagen T.J., Cook J.M., Goldberg S.R., and Katz J.L. Discriminative stimulus effects of intravenous nicotine in squirrel monkeys. Pharmacology, Biochemistry, and Behavior 30 (1988) 243-247
83. Tiffany S.T., Drobes D.J., and Cepeda-Benito A. Contribution of associative and nonassociative processes to the development of morphine tolerance. Psychopharmacology 109 (1992) 185-190
84. Tomie A., Hayden M., and Biehl D. Effects of response elimination procedures upon the subsequent reacquisition of autoshaping. Animal Learning & Behavior 8 (1980) 237-244
85. Ulloa L. The vagus nerve and the nicotinic anti-inflammatory pathway. Nature Reviews Drug Discovery 4 (2005) 673-684
86. US Department of Health and Human Services. Healthy people 2010: Understanding and improving health. 2nd Ed. Washington, DC: US Department of Health and Human Services.
87. Warburton D.M., and Arnall C. Improvements in performance without nicotine withdrawal. Psychopharmacology 115 (1994) 539-542
88. Weeks J.R. Long-term intravenous infusion. In: Myers R.D. (Ed). Methods in psychobiology (1972), Academic Press, New York 155-168
89. Wilkinson J.L., Murray J.E., Li C., Wiltgen S.M., Penrod R.D., Berg S.A., et al. Interoceptive Pavlovian conditioning with nicotine as the conditional stimulus varies as function of number of conditioning trials and unpaired sucrose deliveries. Behavioural Pharmacology 17 (2006) 161-172
90. Wooltorton J.R.A., Pidoplichko V.I., Broide R.S., and Dani J.A. Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas. The Journal of Neuroscience 23 (2003) 3176-3185